Suppr超能文献

针对癌症干细胞簇分化生物标志物的纳米递药系统。

Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers.

机构信息

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Biochemistry, Higher Education Institute of Rab-Rashid, Tabriz, Iran.

Department of Biochemistry, Higher Education Institute of Rab-Rashid, Tabriz, Iran.

出版信息

J Control Release. 2017 Nov 28;266:166-186. doi: 10.1016/j.jconrel.2017.09.028. Epub 2017 Sep 21.

Abstract

Cancer stem cells (CSCs) are one of the most important origins of cancer progression and metastasis. CSCs have unique self-renewal properties and diverse cell membrane receptors that induced the resistance to the conventional chemotherapeutic agents. Therefore, the therapeutic removal of CSCs could result in the cancer cure with lack of recurrence and metastasis. In this regard, targeting CSCs in accordance to their specific biomarkers is a talented attitude in cancer therapy. Various CSCs surface biomarkers have been described, which some of them exhibited similarities on different cancer cell types, while the others are cancer specific and have just been reported on one or a few types of cancers. In this review, the importance of CSCs in cancer development and therapeutic response has been stated. Different CSCs cluster of differentiation (CD) biomarkers and their specific function and applications in the treatment of cancers have been discussed, Special attention has been made on targeted nano-delivery systems. In this regard, several examples have been illustrated concerning specific natural and artificial ligands against CSCs CD biomarkers that could be decorated on various nanoparticulated drug delivery systems to enhance therapeutic index of chemotherapeutic agents or anticancer gene therapy. The outlook of CSCs biomarkers discovery and therapeutic/diagnostic applications was discussed.

摘要

癌症干细胞(CSC)是癌症进展和转移的最重要起源之一。CSC 具有独特的自我更新特性和多样化的细胞膜受体,这导致它们对常规化疗药物产生耐药性。因此,通过治疗去除 CSC 可能会导致癌症治愈,且不会复发和转移。在这方面,根据 CSC 的特定生物标志物来靶向 CSC 是癌症治疗中的一种有前途的方法。已经描述了各种 CSC 表面生物标志物,其中一些在不同的癌细胞类型上表现出相似性,而另一些则是癌症特异性的,仅在一种或几种癌症类型上报道过。在这篇综述中,阐述了 CSC 在癌症发展和治疗反应中的重要性。讨论了不同的 CSC 分化群(CD)生物标志物及其在癌症治疗中的特定功能和应用,特别关注了靶向纳米递药系统。在这方面,已经举例说明了针对 CSC CD 生物标志物的几种特定天然和人工配体,这些配体可以修饰到各种纳米药物递药系统上,以提高化疗药物或抗癌基因治疗的治疗指数。还讨论了 CSC 生物标志物的发现和治疗/诊断应用的前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验